Letter

Two week rule

Breast cancer growth rates favour abolition of rule

BMJ 2007; 335 doi: 10.1136/bmj.39311.468183.3A (Published 23 August 2007)
Cite this as: BMJ 2007;335:361.2

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Emma J Helm, specialist registrar in radiology1,
  2. Edward Nash, specialist registrar in respiratory medicine2
  1. 1Bristol Royal Infirmary, Bristol BS1 3NU
  2. 2Southmead Hospital, Bristol BS10 5NB
  1. emmajhelm{at}hotmail.com

    Potter et al highlight the failure of the two week wait initiative to discriminate between patients with breast cancer and those with benign disease.1

    However, what is more important is whether earlier diagnosis provided by a fast track system improves outcomes for patients. Evidence for this is lacking. This is likely to be due …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular